Comparison of the effects of metformin and glorenta on fatty liver in patients with type 2 diabetes

Phase 3

Recruiting

Conditions: Condition 1: Fatty liver of type 2 diabetic patients. Condition 2: Fatty liver of type 2 diabetic patients. Condition 3: Fatty liver of type 2 diabetic patients. Condition 4: Fatty liver of type 2 diabetic patients.
Fatty (change of) liver, not elsewhere classified
Metabolic syndrome
Nonalcoholic steatohepatitis (NASH)
Diabetes mellitus due to underlying condition
K76.0
E88.81
K75.81

Registration Number: IRCT20210922052550N1

Lead Sponsor: Ilam University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Willingness to cooperate and complete the informed consent form by the patient
Patients over 18 years of age
No pregnancy and lactation
Do not drink alcohol

Exclusion Criteria

Kidney disease
Drugs sensitivity
Diabetic ketoacidosis
Exfoliative dermatitis and angioedema

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determination and comparison of serum levels of alanine aminotransferase at the beginning and end of the study. Timepoint: Measurement of serum levels of alanine aminotransferase at the beginning of the study and three month later. Method of measurement: Serum levels of Alanine aminotransferase will be measured by a reagent laboratory and results will be obtained.

Secondary Outcome Measures

Name	Time	Method
Determining and comparing the ratio of abdominal circumference to hip circumference at the beginning and end of the study. Timepoint: Measure the ratio of abdominal circumference to hip circumference at the beginning of the study and three month later. Method of measurement: Measure the ratio of abdominal circumference to hip circumference using an inelastic meter.;Determining and comparing ultrasound findings at the beginning and end of the study. Timepoint: Perform ultrasound at the beginning of the study and three months later. Method of measurement: Perform ultrasound by the selected ultrasound center and get the results.